Propranolol reduces rat dopamine-beta-hydroxylase activity and catecholamine levels

Area of Science:

• Pharmacology
• Neuroscience
• Cardiovascular Research

Background:

• Beta-adrenergic blockade is a common therapeutic strategy.
• The precise mechanisms by which beta-blockers affect catecholamine synthesis require further elucidation.

Purpose of the Study:

• To investigate the effects of chronic propranolol administration on dopamine-beta-hydroxylase (D beta H) activity and catecholamine levels in specific cardiac and lung tissues.
• To explore the potential for a centrally mediated inhibition of sympathetic activity.

Main Methods:

• Rats were administered propranolol (1 mg/kg i.p. twice daily for 8 days).
• Dopamine-beta-hydroxylase (D beta H) activity and catecholamine (noradrenaline, adrenaline, dopamine) concentrations were measured in atrial, lung, and ventricle tissues, as well as plasma.
• In vitro experiments assessed the direct inhibitory effect of propranolol on tissue D beta H activity.

Main Results:

• Propranolol significantly reduced D beta H activity in the atria (60.5%) and lungs (53.5%), but not ventricles.
• Atrial noradrenaline (NA) levels decreased by 66.3%, adrenaline (A) by 40%, and dopamine (DA) by 72.4%.
• Lung NA levels were reduced by 46.6%, while plasma and ventricle catecholamines remained unchanged. In vitro studies showed no direct inhibition of D beta H by propranolol.

Conclusions:

• Chronic propranolol treatment inhibits noradrenaline synthesis in atrial and lung tissues.
• The findings support a hypothesis of centrally induced sympathetic inhibition mediated by beta-adrenoceptor blockade.
• The lack of effect on ventricle D beta H and catecholamines suggests tissue-specific mechanisms of action.